MOORESTOWN, N.J., June 21, 2018 — Tabula Rasa HealthCare’s (TRHC) (NASDAQ:TRHC) Strategic Advisory Board (SAB) held its third annual meeting June 6 -7 in Philadelphia, PA. The SAB is composed of healthcare influencers and innovators with substantial knowledge of and experience in healthcare, international business, consumer engagement and marketing. The SAB meets annually to collaborate with the Company’s leadership to identify market opportunities and establish pathways to support readiness and success for current and future ventures.
TRHC Chairman, CEO, and Founder Calvin Knowlton, PhD, was pleased with the exchange of ideas. “I’m eager to test and implement many of these strategies,” he said. “They focus on improving healthcare stakeholder value; understanding the consumer as an influencer, buyer, and communicator; and further elevating the role of the pharmacist with tools and technology.”
The two-day program was moderated by SAB member and CEO of Health Intelligence Partners, Jan Berger, MD, MJ. Speakers included several Board members:
Kathy O’Brien, MBA, VP, Marketing, Unilever
Brian Isetts, PhD, Professor, University of Minnesota
Lawrence Lesko, PhD, Professor, University of Florida
Margaret Johnson, RPh, Healthcare Consultant and Former Chief Pharmacy Officer (retired), Horizon Blue Cross Blue Shield of New Jersey
Munish Khaneja, MD, MPH, Chief Medical Officer, Altruista Health.
Topics included “Marketing in a Connected World,” “The Evolving Role of the Pharmacist,” and “The Role of Pharmacy in Value-Based Care.” The meeting also included work sessions to explore trends in technologies as they relate to TRHC’s businesses.
Focusing on understanding the consumer, Ms. O’Brien discussed the drastic change in the consumer journey and spoke of the “holistic sum of consumer experiences” with a brand over time. “It’s important to think of a consumer in totality,” she said. Ms. O’Brien also highlighted the importance of not just engaging consumers, but providing them with a memorable experience to share. “People like to hear about things from their family and friends.”
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.